Labshake search
Citations for BioLegend :
1251 - 1300 of 6121 citations for HCV 1 e2 Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... CD3-AF700 (300324, Biolegend, 1:400), CD4-FITC (357406 ...
-
bioRxiv - Cell Biology 2024Quote: ... and TCRβ (BioLegend, 109204, 1: 50). The iGC B cell culture was performed as described by Nojima et al ...
-
bioRxiv - Cell Biology 2024Quote: ... Anti-Keratin 1 905601(Biolegend, USA) 1:1000 ...
-
bioRxiv - Immunology 2024Quote: ... PD-1- BV650 (EH12.2H7) from Biolegend; CD28- APC- Vio770 (I5E8 ...
-
bioRxiv - Immunology 2024Quote: ... CX3CR1 (clone: 2A9-1) from BioLegend. Amine Aqua dye (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2024Quote: ... CD45.2-PE (BioLegend, 104, 1:800), CD11c-APC (BD ...
-
bioRxiv - Immunology 2024Quote: ... PE-LOX-1 (15C4, Biolegend #358604), BV510-CD11b (ICRF44 ...
-
bioRxiv - Immunology 2024Quote: ... anti-CD357 (GITR) (DTA-1, Biolegend). Treg cells (CD4+Foxp3GFP+CD25+GITR+ ...
-
bioRxiv - Immunology 2024Quote: ... or 7AAD (1:100, BioLegend, #420404).
-
bioRxiv - Immunology 2024Quote: ... SIRPα-PEDazzle594 (BioLegend, P84, 1:1000) and CD8α-PE/Cy7 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... Streptavidin-BV650 (BioLegend 405232, 1:250), CD45.1-BUV737 (Clone A20 ...
-
bioRxiv - Immunology 2024Quote: ... CD301b-PE (BioLegend, clone URA-1), CD25-BV605 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... IgM-PECy5 (BioLegend, clone RMM-1), IgD-PECy7 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... CD301b-APC (BioLegend, clone URA-1), CD301b-PE (BioLegend ...
-
bioRxiv - Microbiology 2024Quote: ... Gr.1 PE (RB6-8C5, BioLegend), F4.80 BV421 (BM8 ...
-
bioRxiv - Microbiology 2024Quote: ... anti-IgG1-APC (RMG1-1, BioLegend), anti-IgG2b-PE (RMG2b-1 ...
-
bioRxiv - Microbiology 2024Quote: ... anti-IgG2b-PE (RMG2b-1, BioLegend), anti-IgG2a-PerCP/Cy5.5 (RMG2a-62 ...
-
bioRxiv - Immunology 2024Quote: ... CD24 (M1/69, BioLegend, 1:100), CD25 (PC61 ...
-
bioRxiv - Cancer Biology 2024Quote: ... C antibody (1:100, Biolegend, #311404) for 40 minutes ...
-
bioRxiv - Microbiology 2024Quote: ... anti-GAPDH (1:1000, BioLegend 919501), anti-GFP (1:200 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and involucrin (1:1000, BioLegend, 924401) using Agilent Dako Autostainer Link 48 and EnVision FLEX kit (Dako) ...
-
bioRxiv - Neuroscience 2024Quote: ... NeuN (BioLegend cat# 834501, 1:2000), alpha-synuclein (ThermoFisher cat# 32-8100 ...
-
bioRxiv - Neuroscience 2020Quote: 250 μg protein from each human brain sample lysate was used for immunoprecipitation (IP) with a combination of Tau12 (Biolegend, cat. no. 806501), Tau 5 (Abcam ...
-
bioRxiv - Neuroscience 2019Quote: ... Supernatants containing 70 µg of total protein were used to determine IL-34 concentration using an IL-34 ELISA kit (BioLegend, San Diego, CA).
-
bioRxiv - Immunology 2021Quote: ... CAR expression analysis was performed using incubation with His-tagged recombinant CD123 protein (SinoBiological, Beijing, China) and secondary staining with αHis-PE or αHis-APC (BioLegend, San Diego, CA). Dead cells were excluded from analysis using LIVE/DEAD Fixable Viability Stains 780 or 575V (BD Horizon ...
-
bioRxiv - Immunology 2024Quote: ... Surface proteins were then stained at 4°C for 30 minutes using the following markers: NIR Zombie dye APC-Cy7 (Biolegend, Cat No. 423105), CD20 PE (Biolegend ...
-
bioRxiv - Neuroscience 2020Quote: ... Sections were incubated with different primary antibodies (Rat-anti-MBP, Sigma-Aldrich MAB386, 1:1000, monoclonal; Rabbit-anti-GFAP, CiteAb Z0334, 1:1000, polyclonal; Mouse-anti-6E10 Amyloid-β, BioLegend SIG-39300, 1:1000, monoclonal) diluted in 200 μl 10% NDS and 0.4% Triton-X blocking medium ON at 4°C ...
-
bioRxiv - Cell Biology 2019Quote: ... organoids were harvested in PBS and digested to a single cell solution in 1:1 Accutase (Biolegend) and TrypLE (Gibco ...
-
bioRxiv - Cell Biology 2019Quote: ... from BD biosciences and APC-Cy7 anti-CD10 (1/100, #312212) PE anti-CD117 (1/100, #313210) from Biolegend.
-
bioRxiv - Cancer Biology 2021Quote: ... organoids were harvested in PBS and digested to a single cell solution in 1:1 Accutase (Biolegend) and TrypLE (Gibco ...
-
bioRxiv - Microbiology 2020Quote: ... or SIV Gag or Env peptides (1 μg/mL) for 1 hour with CD107a PECy5 (eBioH4A3, BioLegend) in R10 media before adding 1 mg/mL of Brefeldin A (Sigma-Aldrich®) ...
-
bioRxiv - Bioengineering 2019Quote: ... and Pacific Blue™ anti-Ly-6G/Ly-6C (Gr-1) (1:70, clone RB6-8C5, Biolegend).
-
bioRxiv - Neuroscience 2019Quote: ... and cells were stained with rat anti-mouse ICAM-1 (1:100; Biolegend YN1/1.7.4 in PerCP), rat anti-mouse CD45 (1:100 ...
-
bioRxiv - Microbiology 2022Quote: ... 1×106 cells were plated and then incubated with Fc block (Biolegend; cat#101320; 1:100 dilution) and surface stained for 20 min at 4°C in the dark ...
-
bioRxiv - Immunology 2023Quote: ... T cell proliferation was stimulated with anti-CD3ε (1 μg/mL)/CD28 (1 μg/mL) antibodies (BioLegend). The anti-CD3ε antibody was coated on each well of the plate via overnight incubation at 4°C with PBS before coculture ...
-
bioRxiv - Immunology 2023Quote: ... 1 × 106 cells were blocked with purified mouse CD16/32 antibody (1:100 dilution; cat. #101301; BioLegend) for 5 minutes on ice ...
-
bioRxiv - Cell Biology 2023Quote: ... Alexa-Fluor®-488 SSEA1 (CD15) (1:50) and Alexa-Fluor®-647 SSEA5 (1:200) (BioLegend). In all experiments ...
-
bioRxiv - Immunology 2023Quote: ... ST2 and CD13 was verified using FITC-coupled anti-FcεRI (1:100, clone MAR-1, BioLegend, #134306), PE-coupled anti-KIT (1:100 ...
-
bioRxiv - Immunology 2023Quote: ... rhIL-2 (50 Uml-1, Novartis) and anti-mIFN-γ (5 µg ml-1, clone XMG1.2, Biolegend) in the presence or absence of 30 mM NaCl ...
-
bioRxiv - Neuroscience 2023Quote: ... The following antibodies in 1:200 dilutions were used: CD31-PE-594 (1:200, Biolegend, Cat# 102520), CD45-APC (1:200 ...
-
bioRxiv - Immunology 2023Quote: ... CD40-APC (1:100) and CD11c-e450 (1:100) (all antibodies from Biolegend, San Diego, CA, USA). Cells were incubated with 100μl of the antibody suspension for 20 minutes at 4°C before a final wash in Ca2+/Mg2+ free PBS containing 2mM EDTA at x400g for 5 minutes at 4°C ...
-
bioRxiv - Cancer Biology 2024Quote: ... approximately 5-10 µg/ml) or purified KPL-1 anti-PSGL-1 mAb (cat. no. 328802, Biolegend). The PL1 hybridoma developed by McEver ...
-
bioRxiv - Genomics 2024Quote: ... at a 1:300 dilution with DAPI 2 μl in 1 ml of 10 μg/ml (BioLegend) and kept on light rotation for 2 h at RT ...
-
bioRxiv - Microbiology 2024Quote: ... and neurons were labelled with rabbit anti-tubulin beta 3 (TuJ-1) IgG at 1:500 (Biolegend), in PBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... mice were anaesthetised as described above and intranasally inoculated with 100ng of carrier free recombinant protein (rIL-1α – Biolegend #575002, rIL-1β – Biolegend #575102) suspended in sterile phosphate buffered saline (PBS) ...
-
bioRxiv - Bioengineering 2023Quote: ... wherein each well mixed 50 μL of X2 photobleached conjugated magnetic beads with 50 μL solutions at different concentrations of a recombinant human Interleukin-8 (IL-8) protein (#574202, BioLegend, San Diego, CA, USA). The overall well concentration levels were 0.05 ...
-
bioRxiv - Neuroscience 2023Quote: ... TruSeq anti-Nuclear Pore Complex Proteins Hashtags were applied to track the brain region of origin for each cell nuclei (BioLegend, CAT: 682205, 682207, 682209). We counterstained nuclei with a far-red DNA fluorescent intercalator ...
-
bioRxiv - Molecular Biology 2020Quote: ... The heme dose response was mixed 1:1 with 2X-concentrated antibodies conjugated to fluorescent dyes (FITC; Biolegend #100510 and eFluor780 ...
-
bioRxiv - Immunology 2021Quote: ... 1×105-1×106 cells were stained after Fc-blocking with TruStain FcX (BioLegend, San Diego, CA, USA) and incubation with Zombie Aqua fixable viability dye (BioLegend ...
-
bioRxiv - Cell Biology 2019Quote: ... APC-eFluor 780 CD25 (1:300; eBioscience, 47-0251-82) and Pe/Cy7 CD28 (1:200; Biolegend, 122014). Subsequently ...